GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 59 filers reported holding GAMIDA CELL LTD in Q2 2022. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $530,000 | +55.0% | 127,595 | -5.1% | 0.01% | +11.1% |
Q4 2021 | $342,000 | -38.7% | 134,462 | -5.5% | 0.01% | -10.0% |
Q3 2021 | $558,000 | +541.4% | 142,295 | +1229.9% | 0.01% | +900.0% |
Q1 2021 | $87,000 | -3.3% | 10,700 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $90,000 | +104.5% | 10,700 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $44,000 | -10.2% | 10,700 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $49,000 | – | 10,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |